A highly potent antibody effective against SARS-CoV-2 variants of concern
Fenwick, C., Turelli, P., Perez, L., Pellaton, C., Esteves-Leuenberger, L., Farina, A., Campos, J., Lana, E., Fiscalini, F., Raclot, C., Pojer, F., Lau, K., Demurtas, D., Descatoire, M., Joo, V. S., Foglierini, M., Noto, A., Abdelnabi, R., Foo, C. S., Vangeel, L., Neyts, J., Du, W., Bosch, B. J., Veldman, G., Leyssen, P., Thiel, V., LeGrand, R., Levy, Y., Trono, D., and Pantaleo, G.
Oct 12, 2021 | Publications